title: What's up with down syndrome and leukemia-A lot!
authors.affiliation: Division of Pediatric Hematology/Oncology, Children's Hospital of Michigan, Michigan, USA. jtaub@med.wayne.edu
authors.forename: Jeffrey W
authors.initials: JW
authors.lastname: Taub
authors.forename: Yaddanapudi
authors.initials: Y
authors.lastname: Ravindranath
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D002675:Child, Preschool; D003561:Cytarabine / Q000008:administration & dosage*; D018572:Disease-Free Survival; D004314:Down Syndrome / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D004317:Doxorubicin / Q000008:administration & dosage / Q000031:analogs & derivatives; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007564:Japan; D015470:Leukemia, Myeloid, Acute / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D008942:Mitoxantrone / Q000008:administration & dosage; D015996:Survival Rate; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D003561:Cytarabine; D014750:Vincristine; D004317:Doxorubicin; D008942:Mitoxantrone; C027260:pirarubicin